Sabine Brookman-May is Senior Vice President, Therapeutic Area Head Urologic Oncology. Before joining Aura, Dr. Brookman-May served as Vice President, Global Research & Development, Bladder Cancer Development Head at Johnson and Johnson Innovative Medicine where she was responsible for the strategic and clinical oversight of the bladder cancer program. Prior to this role, Dr. Brookman-May served in several global research and clinical positions in the field of Urologic Oncology at Johnson and Johnson with increasing complexity and responsibility since 2012, including roles in Medical Affairs Germany and Clinical Operations EMEA. In addition, Dr. Brookman-May holds an academic appointment as a professor in the Department of Urology at Ludwig-Maximilians University Munich. Dr. Brookman-May brings over 20 years of multidisciplinary experience in urology, spanning clinical care, academia, industry and entrepreneurial innovation. She is a board-certified urologist with certificates in both medical tumor treatment and sports medicine and has published more than 200 peer-reviewed papers in the field of urologic oncology.
Management